Target Audience

This international symposium is directed primarily towards academic and private physicians and researchers involved in breast cancer in medical, surgical, gynecologic, and radiation oncology, as well as patient advocates and other appropriate health care professionals. We anticipate 9,500 attendees from more than 100 countries.

Meeting Location 

We are very pleased to announce that the San Antonio Breast Cancer Symposium will take place in 2023. The Symposium offers attendees the unique opportunity to participate in person in San Antonio, Texas or virtually. The dates will be December 5-9, 2023, at the Henry B. Gonzalez Convention Center, 900 E. Market Street, San Antonio, TX 78205 USA.

Preliminary Schedule

Hours subject to change.

Tuesday, December 5
Program: 12:00 PM–6:30 PM

Wednesday, December 6
Program: 7:00 AM–7:00 PM
Exhibits: 12:00 PM–7:00 PM

Thursday, December 7
Program: 7:00 AM–7:00 PM
Exhibits: 12:00 PM–7:00 PM

Friday, December 8
Program: 7:00 AM–6:30 PM
Exhibits: 12:00 PM–4:00 PM

Saturday, December 9
Program: 8:00 AM–11:00 AM

Executive Committee

Carlos L. Arteaga, UT Southwestern, Harold C. Simmons Cancer Center, Dallas, TX, Co-Director
Mark Bonnen, UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX
Margaret Foti, American Association for Cancer Research, Philadelphia, PA
David Gius, UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX
Virginia G. Kaklamani, UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX, Co-Director
Kate Lathrop, UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX (ex-officio)
Dean Post, American Association for Cancer Research, Philadelphia, PA (ex-officio)

Program Planning Committee

Christine Ambrosone, Roswell Park Comprehensive Cancer Center, Buffalo, NY
Carey Anders, Duke Cancer Institute, Durham, NC
Fabrice Andre, Gustave Roussy, Ile de France, France
Carlos L. Arteaga, UT Southwestern, Harold C. Simmons Cancer Center, Dallas, TX
Justin Balko, Vanderbilt University, Nashville, TN
Andrea Barrio, Memorial Sloan Kettering Cancer Center, New York, NY
Mark Bonnen, UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX
Thelma Brown, University of Alabama at Birmingham, Birmingham, AL
Carlos Caldás, University of Cambridge, Cambridge, United Kingdom
Suzanne Conzen, UT Southwestern Medical Center, Dallas, TX
Christina Curtis, Stanford University, Stanford, CA
Carol J. Fabian, University of Kansas Medical Center, Kansas City, KS
Margaret Foti, American Association for Cancer Research, Philadelphia, PA
David Gius, UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX
Shom Goel, Peter MacCallum Cancer Centre, Melbourne, Australia
Virginia G. Kaklamani, UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX
Kate Lathrop, UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX (ex-officio)
Sherene Loi, Peter MacCallum Cancer Centre, Melbourne, Australia
Julia Maues, GRASP, Washington, DC
Heather McArthur, UT Southwestern Medical Center, Dallas, TX
Ann Partridge, Dana-Farber Cancer Institute, Boston, MA
Debra Patt, Texas Oncology, Austin, TX
Charles M. Perou, University of North Carolina, Chapel Hill, NC
Manjeet Rao, UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX
Pedram Razavi, Memorial Sloan Kettering Cancer Center, New York, NY
Mothaffar Rimawi, Baylor College of Medicine, Houston, TX
Kalliopi Siziopikou, Northwestern University, Chicago, IL
Melinda Telli, Stanford University School of Medicine, Stanford, CA
Neil Vasan, Columbia University Irving Medical Center, New York, NY
Antonio Wolff, Johns Hopkins University, Baltimore, MD
Richard Zellars, Indiana University School of Medicine, Indianapolis, IN

Proof of Attendance

A statement verifying your participation at the 2023 Symposium will be emailed to all attendees on Friday, December 8, 2023.

Certificate of Attendance/CME Certificate

Physicians seeking CME credit for this live continuing medical education activity or a Certificate of Attendance must complete the surveys for 2023 SABCS. Surveys open on December 5, 2023 and close on January 31, 2024. The deadline to complete your session evaluations and post survey is January 31, 2024.  

  

Advocate Financial Assistance

Patient advocates wishing to apply for financial assistance for the 2023 SABCS should contact the Alamo Breast Cancer Foundation for information and an application. Applications are available online. Please see their website for more information and qualifications. Applications must be post-marked by September 1, 2023.

Email: alamoadvocateprogram@gmail.com

Web: www.alamobreastcancer.org

Awards

The William L. McGuire Memorial Lectureship

Dr. William L. McGuire, along with Dr. Charles A. Coltman, founded the San Antonio Breast Cancer Symposium in 1977. The William L. McGuire Memorial Lectureship was established in 1992 to commemorate the significant contributions of Dr. McGuire to oncology medicine. His research played a major role in introducing estrogen receptor assays on breast tumor tissue as a guide to treatment decisions for women with breast cancer. Breast cancer patients everywhere now receive these tests.

The lecturer is selected by the SABCS McGuire Award Committee from persons through a nomination process. The selection is based on the following criteria:

• Lecturers are respected figures with an international reputation.

• They have made significant contributions to the field of breast cancer research.

• They are known as skilled presenters.

• They present a topic of high current interest related to the diagnosis and treatment of breast cancer or to the study of its underlying   mechanisms.

AACR Outstanding Investigator Award for Breast Cancer Research, funded by The Breast Cancer Research Foundation

The AACR Outstanding Investigator Award for Breast Cancer Research is presented to an investigator no more than 50 years of age whose novel and significant work that has had or may have a far-reaching impact on the etiology, detection, diagnosis, treatment, or prevention of breast cancer.

AACR Distinguished Lectureship in Breast Cancer Research

The AACR Distinguished Lectureship in Breast Cancer Research has been established to recognize outstanding science that has inspired or has the potential to inspire new perspectives on the etiology, diagnosis, treatment, or prevention of breast cancer.

Embargo

Abstracts, with the exception of those withheld for SABCS press conferences, will be released approximately one month prior to the symposium. The abstracts withheld for press will be released at the beginning of the day on which the relevant press conference occurs.

Reporters, producers and editors agree to the embargoes and release times stated on the news releases, the news conference schedule and other materials. Failure to abide by the embargoes will result in suspension of credentials, which will affect attendance at the current and future symposia and ability to receive advance press materials.

By allowing an abstract to be included in the 2023 San Antonio Breast Cancer Symposium media outreach program, the Presenter verifies that the abstract’s contents and its conclusions have not been and will not be published or presented in any form to the public before the start of the actual presentation. This includes, but is not limited to, non-embargoed press releases and interviews required by government agencies. Any release of material and specific non-embargoed information prior to the meeting’s embargo date as set forth by the SABCS press office could result in exclusion from the official SABCS press program.

Please see the media page for more information